U.S. market Open. Closes in 5 hours

LXRX | Lexicon Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
Revenue1.20M139.00K298.00K24.00M322.07M63.21M90.33M83.34M130.01M22.85M2.22M1.09M1.85M4.91M10.70M32.32M50.12M72.80M75.68M61.74M42.84M35.20M305.58M14.46M4.70M
Cost of Revenue639.00K427.00K55.05M1.93M3.23M2.49M1.90MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-2.62M-2.00M
Gross Profit565.00K-288.00K-54.75M22.07M318.84M60.72M88.44MN/AN/AN/AN/AN/A1.85M4.91M10.70MN/AN/AN/AN/AN/AN/AN/AN/A17.08M6.70M
Operating Expenses172.31M100.90M87.39M200.85M148.76M164.00M223.02M221.19M119.02M108.69M106.80M99.62M115.94M100.63M100.66M128.86M125.07M128.03M111.80M109.19M105.43M98.09M349.22M52.56M19.50M
Selling, General & Admin113.98M48.08M32.34M47.23M56.84M63.75M66.20M43.04M23.84M19.41M17.12M17.04MN/A22.57M19.42MN/AN/AN/AN/AN/AN/AN/A20.86M18.29MN/A
Research & Development58.33M52.82M55.05M153.62M91.92M100.24M156.81M178.15M95.19M89.28M89.68M82.57M91.83M75.35M81.24M108.58M104.33M106.69M93.62M90.59M82.20M74.86M53.35M31.65M14.60M
Other Operating Expenses-58.89MN/AN/A1.60M28.64MN/AN/AN/AN/AN/AN/AN/A24.12M2.71MN/A20.28M20.74M21.33M18.17M18.61M23.23M23.23M275.00M2.62M4.90M
Operating Income-171.75M-100.76M-87.09M-178.78M141.44M-103.28M-136.68M-137.86M10.99M-85.84M-104.58M-98.53M-114.09M-95.72M-89.96M-96.53M-74.95M-55.23M-36.12M-47.45M-62.59M-62.89M-43.64M-35.48M-12.80M
Other Expenses / Income-5.37M-1.18M-668.00K120.21M-17.33M-17.27M-5.03M-3.57M-15.67M-14.53M455.00K-11.68M-2.12M-6.08M-3.46M-349.00K3.72M109.66M75.31M1.30MN/AN/AN/AN/AN/A
Before Tax Income-177.12M-101.94M-87.76M-58.57M124.12M-120.55M-141.71M-141.43M-4.68M-100.36M-104.13M-110.21M-116.22M-101.80M-93.42M-96.88M-71.23M54.43M39.20MN/AN/AN/AN/AN/AN/A
Income Tax Expenses386.11K1.18M510.00K11.61M-6.01M3.51M-12.66MN/AN/A-70.00KN/AN/AN/A-26.00K-102.00KN/AN/A-119.00K119.00KN/AN/AN/AN/AN/AN/A
Net Income-177.12M-103.13M-88.27M-70.18M130.13M-120.55M-129.05M-141.43M-4.68M-100.29M-104.13M-110.21M-116.22M-101.78M-82.78M-76.86M-58.79M-54.31M-36.31M-47.17M-64.20M-59.67M-35.17M-25.99M-12.50M
Interest Expenses13.10M2.78M802.00K14.54M20.68M20.78M6.98M6.57M6.72M2.25M1.97M2.11M2.53M2.72M2.97M2.69M2.77M3.25M3.28M2.66M325.00K7.00K314.00K422.04KN/A
Basic Shares Outstanding221.13M165.73M145.65M110.84M106.22M105.83M105.24M103.86M103.59M76.35M73.30M69.96M48.68M43.26M20.78M19.54M14.26M9.55M9.14M9.05M8.12M7.47M7.17M5.95M3.37M
Diluted Shares Outstanding221.13M165.73M145.65M110.84M116.75M105.83M105.24M103.86M103.59M76.35M73.30M69.96M48.68M43.26M20.78M19.54M14.26M9.55M9.14M9.05M8.12M7.47M7.17M5.95M3.37M
EBITDA-171.20M-99.16M-86.96M-176.02M173.43M-99.77M-131.33M-132.81M2.77M-96.18M-99.29M-103.91M-108.80M-93.69M-73.76M-64.10M-45.60M-39.98M-21.28M-31.64M-42.34M-39.08M-18.31M-22.95M-10.50M
EBITDA Margin-14,218.94%-71,341.01%-29,179.87%-733.56%53.85%-157.84%-145.38%-159.36%2.13%-420.86%-4,468.59%-9,541.51%-5,884.26%-1,908.88%-689.32%-198.32%-90.99%-54.91%-28.12%-51.25%-98.84%-111.03%-5.99%-158.74%-223.40%
EBIT-163.63M-99.16M-86.96M-44.03M144.79M-96.26M-134.73M-134.86M2.04M-98.11M-102.16M-108.10M-113.69M-99.08M-79.92M-74.17M-56.02M-51.18M-32.92M-44.51M-63.87M-59.66M-34.86M-25.57M-12.50M
EBIT Margin-13,590.69%-71,341.01%-29,179.87%-183.50%44.96%-152.29%-149.14%-161.83%1.57%-429.29%-4,597.43%-9,926.26%-6,148.57%-2,018.79%-746.88%-229.48%-111.78%-70.30%-43.49%-72.10%-149.10%-169.50%-11.41%-176.86%-265.96%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙